These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12810046)

  • 1. Decrease of intestinal P-glycoprotein activity by 2n-propylquinoline, a new oral treatment for visceral leishmaniasis.
    Belliard AM; Leroy C; Banide H; Farinotti R; Lacour B
    Exp Parasitol; 2003; 103(1-2):51-6. PubMed ID: 12810046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies.
    Rocha-Pereira C; Ghanem CI; Silva R; Casanova AG; Duarte-Araújo M; Gonçalves-Monteiro S; Sousa E; Bastos ML; Remião F
    Toxicol Appl Pharmacol; 2020 Jan; 386():114832. PubMed ID: 31756430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
    Parasrampuria DA; Lantz MV; Benet LZ
    Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antileishmanial properties of a 2-n-propylquinoline hydroxypropyl β-cyclodextrin formulation and pharmacokinetics via intravenous route.
    Balaraman K; Vieira NC; Moussa F; Vacus J; Cojean S; Pomel S; Bories C; Figadère B; Kesavan V; Loiseau PM
    Biomed Pharmacother; 2015 Dec; 76():127-33. PubMed ID: 26653559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF
    Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of some P-glycoprotein modulators on Rhodamine-123 absorption in guinea-pig ileum.
    Colabufo NA; Berardi F; Contino M; Inglese C; Niso M; Perrone R
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3741-4. PubMed ID: 18524592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of P-glycoprotein in berberine absorption.
    Pan GY; Wang GJ; Liu XD; Fawcett JP; Xie YY
    Pharmacol Toxicol; 2002 Oct; 91(4):193-7. PubMed ID: 12530470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.
    Yamamoto W; Verweij J; de Bruijn P; de Jonge MJ; Takano H; Nishiyama M; Kurihara M; Sparreboom A
    Anticancer Drugs; 2001 Jun; 12(5):419-32. PubMed ID: 11395570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the human cytochrome P450s involved in the metabolism of 2n-propylquinoline.
    Belliard AM; Baune B; Fakhfakh M; Hocquemiller R; Farinotti R
    Xenobiotica; 2003 Apr; 33(4):341-55. PubMed ID: 12745870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileishmanial activity of a formulation of 2-n-propylquinoline by oral route in mice model.
    Campos Vieira N; Vacus J; Fournet A; Baudouin R; Bories C; Séon-Méniel B; Figadère B; Loiseau PM
    Parasite; 2011 Nov; 18(4):333-6. PubMed ID: 22091464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R; Surry DD; Smith VN; Gray AJ
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
    Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
    Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion.
    Veau C; Leroy C; Banide H; Auchère D; Tardivel S; Farinotti R; Lacour B
    Nephrol Dial Transplant; 2001 Aug; 16(8):1607-14. PubMed ID: 11477162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional difference in P-glycoprotein function in rat intestine.
    Iida A; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs.
    Miao Q; Wang Z; Zhang Y; Miao P; Zhao Y; Zhang Y; Ma S
    Pharm Biol; 2016 Sep; 54(9):1548-56. PubMed ID: 26810690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose-induced metabolic syndrome decreases protein expression and activity of intestinal P-glycoprotein.
    Novak A; Godoy YC; Martinez SA; Ghanem CI; Celuch SM
    Nutrition; 2015 Jun; 31(6):871-6. PubMed ID: 25933496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    Pharm Res; 1998 Jul; 15(7):1001-6. PubMed ID: 9688051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein.
    Prueksaritanont T; Meng Y; Ma B; Leppert P; Hochman J; Tang C; Perkins J; Zrada M; Meissner R; Duggan ME; Lin JH
    Xenobiotica; 2002 Mar; 32(3):207-20. PubMed ID: 11958560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.